A method called G&T-seq physically separates single-cell DNA from messenger RNA for subsequent sequencing.
The microbiome sequencing firm has analyzed millions of data points from a citizen science project to develop clinical assays.
By sequencing the exomes of breast cancer patients from founder populations, researchers have uncovered a novel breast cancer susceptibility gene.
The institute is offering whole-genome sequencing starting at $2,800, which includes the sequencing and initial interpretation.
The deal will allow LifeLabs to perform Natera's Panorama NIPT in Canada and follows a prior agreement for LifeLabs to distribute the test in that country.
In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.
Stanford University researchers are studying top athletes to uncover genes linked to performance.
The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.
This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.